The Effect of YiQiFuMai on Ischemic Heart Failure by Improve Myocardial Microcirculation and Increase eNOS and VEGF Expression

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.org/journal/ijcm
E-mail: ijcm@scirp.org

Citations

"The Effect of YiQiFuMai on Ischemic Heart Failure by Improve Myocardial Microcirculation and Increase eNOS and VEGF Expression"
written by Shuren Li, Xiao Hao, Sa Xiao, Liying Xun,
published by International Journal of Clinical Medicine, Vol.11 No.2, 2020

has been cited by the following article(s):

[1]	Mesenchymal Stem Cells Derived from Human Amniotic Membrane Increase VEGF and Extenuate Fibrosis in Heart Failure Rats
	Iranian Journal of …, 2022

[2]	Virtual screening as therapeutic strategy of COVID-19 targeting angiotensin-converting enzyme 2
	2021

[3]	Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV
	2020

[1]	Exercise ameliorates cardiac injury induced by nandrolone decanoate through downregulation of osteopontin and mTOR expressions Tissue and Cell, 2025 DOI:10.1016/j.tice.2025.102932

[2]	Cardiovascular Effects of Long-Term Treatment with Enhanced External Counterpulsation in Patients with Ischemic Heart Failure: Randomized, Placebo-Controlled, Open-Label Clinical Trial Journal of Cardiovascular Development and Disease, 2025 DOI:10.3390/jcdd12090352

[3]	Mesenchymal Stem Cells Derived from Human Amniotic Membrane Increase VEGF and Extenuate Fibrosis in Heart Failure Rats Iranian Journal of Science and Technology, Transactions A: Science, 2022 DOI:10.1007/s40995-022-01307-4

[4]	Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV European Journal of Clinical Microbiology & Infectious Diseases, 2020 DOI:10.1007/s10096-020-03883-y